Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push…
“60 Minutes” correspondent Scott Pelley paid tribute Sunday to Bill Owens, the show’s executive producer who resigned last week, saying…
If President Donald Trump’s 145% levy against imports from China holds, Hasbro estimates it could see as much as a $300…
U.S. spirit exports reached a record $2.4 billion in 2024, driven in large part by tariff concerns and ongoing…
OKLAHOMA CITY — Amazon and Nvidia executives said Thursday that the construction of artificial intelligence data centers is not…
OKLAHOMA CITY — Amazon and Nvidia executives said Thursday that the construction of artificial intelligence data centers is not…
Berry unicorn startup Fruitist has surpassed $400 million in annual sales, thanks to the success of its long-lasting jumbo…
LOS ANGELES — A group of California homeowners is taking on insurance companies that they say illegally coordinated to…
Starbucks is imposing new limits on what its baristas can wear under their green aprons. Starting May 12, employees will…